Acasti Pharma (ACST) Earnings Date, Estimates & Call Transcripts $3.37 -0.03 (-0.88%) (As of 10/25/2024) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Acasti Pharma Latest Earnings SummaryLatest Q1 2025 Earnings DateAug. 9EstimatedActual EPS (Aug. 9) -$0.24 Beat By $0.04 Consensus EPS (Aug. 9) -$0.28 Acasti Pharma issued Q1 2025 earnings on August 9, 2024, reporting an EPS of -$0.24, which topped analysts' consensus estimates of -$0.28 by $0.04. With a trailing EPS of -$1.44, Acasti Pharma's earnings are expected to grow next year, from ($1.11) to ($0.75) per share. Get Acasti Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acasti Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataACST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ACST Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Investors AlleyWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…Click here to discover the new #1 way to invest in Tesla Acasti Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.63-$0.63-$0.63Q2 20241-$0.29-$0.29-$0.29Q3 20241-$0.30-$0.30-$0.30Q4 20241-$0.35-$0.35-$0.35FY 20244-$1.57-$1.57-$1.57Q1 20251-$0.28-$0.28-$0.28Q2 20251-$0.34-$0.34-$0.34Q3 20251-$0.30-$0.30-$0.30Q4 20251-$0.23-$0.23-$0.23FY 20254($1.15)($1.15)($1.15) Acasti Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/9/2024Q1 2025-$0.28-$0.24+$0.04-$0.24--6/21/2024Q4 2024-$0.48-$0.18+$0.30-$0.10--2/12/2024Q4 2023-$0.23-$0.21+$0.02-$0.21--11/13/2023Q2 2024-$0.29-$0.19+$0.10$0.05--8/11/2023Q1 2024-$0.63-$0.34+$0.29-$0.14--6/23/2023Q4 2023-$0.78-$0.30+$0.48$3.30-- Get the Latest News and Ratings for ACST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/14/2023Q3 2023-$0.78-$0.54+$0.24-$0.09--11/14/2022Q2 2023--$0.66 -$0.66-$0.11-- Acasti Pharma Earnings - Frequently Asked Questions When did Acasti Pharma announce their last quarterly earnings? Acasti Pharma (NASDAQ:ACST) last announced its quarterly earning data on Friday, August 9, 2024. Learn more on ACST's earnings history. Did Acasti Pharma beat their earnings estimates last quarter? In the previous quarter, Acasti Pharma (NASDAQ:ACST) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.28) by $0.04. Learn more on analysts' earnings estimate vs. ACST's actual earnings. How much profit does Acasti Pharma generate each year? Acasti Pharma (NASDAQ:ACST) has a recorded net income of -$12.85 million. ACST has generated -$1.44 earnings per share over the last four quarters. What is Acasti Pharma's EPS forecast for next year? Acasti Pharma's earnings are expected to grow from ($1.11) per share to ($0.75) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies TELO Earnings INMB Earnings PDSB Earnings ME Earnings ANIX Earnings FBLG Earnings ALVR Earnings IPSC Earnings IVVD Earnings DERM Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run What are you hiding Elon?? (Tesla’s secret 69% dividend) (Ad)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…Click here to discover the new #1 way to invest in Tesla This page (NASDAQ:ACST) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhat are you hiding Elon?? (Tesla’s secret 69% dividend)Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acasti Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
